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ABSTRACT: The prevalence of hospital-acquired infections
(HAIs) caused by multidrug-resistant bacteria is a growing
public health concern worldwide. Herein, a facile, easily
scalable technique is reported to fabricate white-light-activated
bactericidal surfaces by incorporating zinc oxide (ZnO)
nanoparticles and crystal violet (CV) dye into poly-
(dimethylsiloxane). The eﬀect of ZnO concentration on
photobactericidal activity of CV is investigated, and we show
that there is synergy between ZnO and CV. These materials
showed highly signiﬁcant antibacterial activity when tested
against Staphylococcus aureus and Escherichia coli under white
light conditions. These surfaces have potential to be used in
healthcare environments to decrease the impact of HAIs.
1. INTRODUCTION
Hospital-acquired infections (HAIs) are among the most
serious complications of hospital care associated with extended
duration of hospital stays, increased morbidity, and increased
medical costs. According to the U.S. Center of Disease Control
and Prevention, about 1 in 25 hospital patients acquires at least
1 HAI, equivalent to 722 000 infections in the U.S. in 2011, and
resulting in 75 000 deaths during hospitalization.1 The
treatment of these infections costs to the U.S. government
app. $35−$45 billion per year.2 In the U.K., 300 000 healthcare-
associated infections occur each year and cost over £1 billion to
the National Health Service (NHS). In healthcare facilities,
80% of infections are because of contaminated touch surfaces.
Therefore, new antimicrobial surfaces need to be developed to
minimize the risk of spreading bacteria.
A number of studies have reported novel and eﬃcient
antimicrobial surfaces including surfaces releasing micro-
bicides,3,4 antibiotics,5,6 and quaternary ammonium salts7,8
and copper surfaces.9,10 Photodynamic therapy (PDT) has
been raised as a promising alternative to current techniques.11
Antimicrobial photodynamic therapy, a type of PDT, is based
on the use of nontoxic light-activated antimicrobial agents
(LAAAs), known as photosensitizers, that are irradiated by a
light source with an appropriate wavelength.12 In this process,
these agents produce reactive oxygen species (ROS) that act on
bacteria via multiple attack pathways including the oxidative
destruction of cellular membranes, intracellular proteins, and
DNA. Given the multiple targets of ROS, the emergence of
bacterial resistance is extremely unlikely.13−15
Zinc oxide (ZnO) is an inexpensive, wide band gap (3.3 eV
at room temperature) semiconducting material that has
excellent optical and electronic properties, ﬁnding a wide
range of applications from ﬁeld eﬀect transistors to gas sensors
and in dye-sensitized solar cells.16 Moreover, ZnO has the
inherent advantage of showing antibacterial activities against a
broad range of Gram-positive and Gram-negative bacteria.17−19
The antibacterial activity of ZnO has been well exploited under
irradiation with light (UV or white light) and in the absence of
light.19−23 Similar to that of LAAAs, the proposed mechanism
of its antibacterial activity is thought to be via oxidative stress as
a result of ROS production.24
Regarding surface application of LAAAs, it has been
previously demonstrated that photosensitizers (e.g., crystal
violet (CV) and methylene blue) can be successfully
encapsulated into a variety of diﬀerent polymers by a facile
“swell−encapsulation−shrink” technique25−27 and these poly-
mers demonstrate eﬃcacious photoactivated antibacterial
activity under irradiation with white light. Also, dye-
immobilized polymeric materials have demonstrated an
enhanced photobactericidal activity when incorporated with
diﬀerent nanoparticles (NPs) (e.g., silver and gold).26,28,29 Even
though these materials show potent photobactericidal activity,
they include complex, labor-intensive, time-consuming syn-
thesis of NPs. Also, these NPs can be implemented only to soft
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materials such as polymers and silicones by the swell−
encapsulation−shrink process.
In our previous work, poly(dimethylsiloxane) (PDMS)/ZnO
NP composites with 0.36 wt % ZnO were fabricated through a
solvent-aided dispersion process using chloroform as a
solvent.30 Then, ZnO-incorporated polymer squares were
coated with CV and these samples induced the lethal
photosensitization of Escherichia coli within 4 h and Staph-
ylococcus aureus within 1 h under white light conditions (∼10
500 lux).30
In the present study, a similar, but a simpler, more versatile
and scalable approach is reported for fabricating highly
eﬃcacious white-light-activated self-sterilizing surfaces based
on three components ZnO NPs, CV, and PDMS to overcome
the aforementioned problems. The main objective of this study
was to investigate whether the photobactericidal activity of CV
is inﬂuenced by the ZnO content. Also, we utilized a lower
white light intensity compared to that in the previous work
(∼6500 lux) in antimicrobial tests. The results showed that the
synergistic combination of CV and ZnO NPs led to superior
antibacterial activity of the polymers.
2. RESULTS AND DISCUSSION
2.1. Materials Synthesis. CV and ZnO NPs were
incorporated into PDMS by a simple two-step procedure to
fabricate a potent bactericidal polymer−nanocomposite (Figure
1). The ﬁrst step involved mixing ∼60 nm ZnO NPs (see
Supporting Information, Figure S2a) with PDMS by mechan-
ical rabbling on the basis of a series of PDMS/ZnO NPs with
varying nanoparticle content, as shown in Table 1. Then, the
resultant milky polymer was degassed under vacuum to remove
entrapped air bubbles. Finally, the polymer was cast on glass
substrates and cured in a preheated oven at 100 °C. Whereas
PDMS is transparent, the ZnO-embedded polymers are white
(Figure 2).
In the second step, these modiﬁed polymers were coated
with CV using a swell−encapsulation−shrink method. In this
process, the polymer squares were dipped and left to swell in
750 ppm CV solutions in acetone for 24 h under dark
conditions. Acetone induced polymer swelling, allowing dye
penetration through the polymer matrix. After removing from
the solution, the swollen polymer had shrunk to its original
dimensions as the remaining solvent evaporated. This method
generated dark purple polymer squares, indicating an eﬃcacious
uptake of the dye onto the polymer surfaces (Figure 2).
Figure 1. Schematic view and process ﬂow of the polymer paint containing ZnO and CV.
Table 1. Polymer Matrices Embedded with the
Photosensitizer Dye and Diﬀerent ZnO NP Contents
Represented by Various Sample IDs and Average Contact











PDMS (control) 10.0 − 97.0 ± 1.80
CV 10.0 + 100.8 ± 0.82
0.5ZnO 0.05 10.0 − 96.1 ± 3.51
0.5ZnO−CV 0.05 10.0 + 102.9 ± 3.30
1.0ZnO 0.10 10.0 − 98.3 ± 1.57
1.0ZnO−CV 0.10 10.0 + 99.5 ± 1.37
5.0ZnO 0.50 10.0 − 100.0 ± 4.62
5.0ZnO−CV 0.50 10.0 + 102.4 ± 0.98
Figure 2. Photograph of the PDMS/ZnO samples with diﬀerent
nanoparticle contents (0.5−5.0 wt %): samples before (on the top)
and after (on the bottom) the swell−encapsulation−shrink process.
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2.2. Material Characterization. Figure S3 shows the
infrared absorbance spectra of the polymer ﬁlms, from which
no signiﬁcant change was conﬁrmed across the ZnO/PDMs
composite ﬁlms from 0 to 5 wt % of ZnO nanoparticle
concentration before and after the swell−encapsulation−shrink
process. The similarity between the untreated and treated
samples can be due to the strong PDMS absorbance bands and
the low concentrations of dye present in the polymer samples.
Consequently, the results indicate that the incorporation of
ZnO NPs and CV in the silicones had no signiﬁcant inﬂuence
on the internal structures of the ﬁlms within the detection limit
of Fourier transform infrared (FT-IR).
The presence of the ZnO NPs was conﬁrmed by X-ray
diﬀraction (XRD), photoluminescence (PL) spectroscopy, and
functional testing of the polymer ﬁlms. The X-ray diﬀraction of
neither the 0.5ZnO nor the 1.0ZnO sample displayed any
discernible reﬂection because of the low density of the ZnO
NPs embedded within the polymers, whereas phase-pure ZnO
in the wurtzite crystal structure was appeared when ZnO
concentration increased to 5.0 wt % (Figure 3b) (peaks at 2θ =
31.7, 34.4, 36.2, 47.6, and 56.5° assigned to (100), (002),
(101), (102), and (110) planes, respectively). Also, it can be
seen that the incorporation of CV into the polymer does not
impact the internal structure of the polymer ﬁlm, in good
agreement with the experimental results of Figure S3.
Photoluminescence measurements were made on the PDMS-
encapsulated materials with and without CV coating (Figure 4).
The ZnO-incorporated samples without CV displayed a clear,
broad ﬂuorescence band, peaking at ca. 520 nm, increasing in
intensity with increasing ZnO loading. This is in agreement
with reported values for ZnO nanoparticles of this size and with
a powder sample of ZnO measured ex situ of the PDMS.31,32
On coating with CV, the ZnO emission band is overwhelmed
by CV emission.
The treated PDMS samples were also characterized using
UV−vis absorbance spectroscopy (Figure 5). The main and
shoulder absorption peaks of PDMS containing CV alone are at
λ ≈ 590 and 533 nm, respectively. The addition of ZnO NPs
increased the maxima, intensity, and breadth of the CV peak,
indicating that dye uptake was enhanced by increasing the ZnO
concentration. This phenomenon has been demonstrated in
another study in which gold nanoparticles enhanced the UV−
visible absorption of toluidine blue.33 However, for 5.0ZnO−
CV, the absorption reached its maximum as expected because
5.0ZnO−CV was darker in color compared with any other CV-
coated sample. The CV concentrations within the polymer
were found to be 1.17 × 10−4, 6.64 × 10−4, 8.50 × 10−4, and
Figure 3. XRD patterns of (a) ZnO nanopowder and (b) PDMS, 5.0ZnO, and 5.0ZnO−CV. The peaks were indexed to a polycrystalline wurtzite
structure.
Figure 4. PL spectra of (a) ZnO nanopowder and (b) ZnO/PDMS composites.
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1.07 × 10−3 for PDMS, 0.5Zn−CV, 1.0Zn−CV, and 5.0Zn−
CV, respectively.
Moreover, a characteristic absorption peak at 375 nm for
ZnO NPs suspended in water was seen in the range of UV (see
Supporting Information, Figure S2b), indicating that ZnO NPs
are UV-activated photocatalysts (<385 nm) and hence should
not show signiﬁcant antibacterial activity under white light
conditions. However, when encapsulated in PDMS, there was
no characteristic UV−vis peak of ZnO because of high
nanoparticle concentrations.
Wetting properties of the samples were characterized by
contact angle (CA) measurements using water as a test liquid.
Figure 5. UV−visible absorbance spectra for (a) CV, (b) 0.5ZnO−CV, and (c) 1.0ZnO−CV.
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As demonstrated in Table 1, bare PDMS is inherently
hydrophobic having a CA of 97.0 ± 1.8°, whereas no signiﬁcant
diﬀerence in the wetting properties of the treated samples was
observed, varying in contact angle by ±6°.
To examine whether there was leaching of the dye-
incorporated polymers, they were placed in 10 mL of
phosphate-buﬀered saline (PBS) solution at 37 °C and the
CV leachates were measured spectroscopically as a function of
time (Figure 6). It can be seen that all of the CV-coated
samples leached dye into PBS after 24 h and that the amount of
CV leaching was correlated with increasing the nanoparticle
weight. Over a period of more than 300 h, the CV
concentration of all of the samples plateaus at below 8.5 ×
10−7 M and, overall, no further leaching was observed,
indicating stability of the dye in the polymers. Crystal violet,
a topical antiseptic, possesses antibacterial and antifungal
properties.34 It is still listed by the World Health Organization
even though new drugs have superseded its use in the medical
ﬁeld, and clinical trials showed its eﬃciency to treat infected
wounds, superﬁcial skin, and methicillin-resistant S. aureus
infections.35,36 Hence, if there is signiﬁcant leaching of the dye,
it is not expected to show toxicity toward human cells.
In addition, a similar setup was used to detect whether the
ZnO-incorporated samples release nanoparticles into PBS
solution. There was no observable change in the amount of
leaching, color, or conductivity of the solution (data not
shown), showing that the ZnO in the polymer matrix is more
stable to leaching in contrast to CV.
2.2.1. Antibacterial Investigation. The bactericidal proper-
ties of the following PDMS samples were examined against a
Gram-positive bacterium, S. aureus 8325-4, and a Gram-
negative bacterium, E. coli ATCC 25922, under dark and
light conditions: undoped PDMS polymer (control), zinc
oxide-incorporated PDMS (ZnO), crystal violet-coated PDMS
(CV), 0.5% ZnO-doped PDMS (0.5ZnO), 0.5% ZnO-doped
PDMS with CV (0.5ZnO−CV), 1% ZnO-doped PDMS
(1.0ZnO), 1% ZnO-doped PDMS with CV (1.0ZnO−CV),
5% ZnO-doped PDMS (5.0ZnO), and 5% ZnO-doped PDMS
with CV (5.0ZnO−CV). The photobactericidal activity of the
CV-coated PDMS samples was activated with a white light
Figure 7. Number of viable colony counts of S. aureus 8325-4 on treated PDMS squares after incubation in the dark and in white light for 45 min.
The orange and purple asterisks indicate S. aureus levels below detection limits.
Figure 8. Number of viable colony counts of E. coli ATCC 25922 on treated PDMS squares after incubation in the dark and in white light for 45
min. The purple asterisk indicates E. coli levels below detection limits.
ACS Omega Article
DOI: 10.1021/acsomega.7b01473
ACS Omega 2018, 3, 3190−3199
3194
source emitting an average light intensity of 6500 ± 300 lux at a
distance of 25 cm from the samples (see Supporting
Information, Figure S4). Also, a control sample set was tested
in the dark for the same exposure times.
Figure 7 demonstrates the bactericidal activities of the
samples against S. aureus after 45 min of incubation in the dark
and in white light. Under dark conditions, none of the polymer
samples showed statistically signiﬁcant reduction in S. aureus
numbers. Similarly, in white light, no signiﬁcant killing of S.
aureus was observed on the 0.5ZnO sample surface compared
to that on the control sample. However, a greater reduction in
bacterial numbers was apparent on the surfaces of both the
1.0ZnO and 5.0ZnO samples (P-value < 0.01 for both).
Furthermore, the 0.5ZnO−CV sample caused ∼1 log reduction
in the number of viable bacteria, with enhanced killing
compared to that on the sample containing CV alone (0.35
log reduction). The eﬀect of both the 1.0ZnO−CV and
5.0ZnO−CV samples was even more remarkable, reducing
bacterial counts to below the detection limit (≥4 log, P-value =
0.002) in the light, within 45 min.
The antibacterial properties of the same polymers were also
investigated against E. coli under the same conditions but with a
longer exposure time (Figure 8). In the dark, over a 90 min
period, no statistically signiﬁcant decrease in the numbers of E.
coli was demonstrated by the samples containing ZnO NPs
relative to that by the control polymer. On the other hand,
except the polymer containing CV alone, all of the samples
containing ZnO and coated with CV displayed statistically
signiﬁcant (P-value < 0.01) activity compared to that of the
control sample.
After 90 min of white light exposure, the 0.5ZnO−CV
sample and the 1.0ZnO−CV sample achieved 0.70 log and 1.33
log reductions in the numbers of E. coli (Figure 8). Moreover,
the 5.0ZnO−CV sample displayed a highly signiﬁcant reduction
in bacterial numbers after 90 min of irradiation, with bacterial
counts reduced to below the detection limit (≥4 log, P-value =
0.002).
The diﬀerence between the susceptibilities of the Gram-
positive (S. aureus) and the Gram-negative (E. coli) bacteria is
most probably because of the diﬀerences in their cell wall
structures.37 Whereas Gram-positive bacteria possess a single
thick peptidoglycan layer (20−80 nm), Gram-negative bacteria
contain a thinner peptidoglycan layer (7−8 nm) but possess a
second (outer) membrane,16 reducing the permeability of
radicals and making them less susceptible to dye-coated
polymeric surfaces.38,39 Overall, the results show that the
polymer containing ZnO or CV alone does not possess potent
antibacterial properties. Hence, it is required to combine both
agents into the polymer to fabricate a superior self-sterilizing
material that shows eﬃcacious photobactericidal activity against
both E. coli and S. aureus.
To evaluate the eﬃcacy of these polymeric surfaces, their
photobactericidal properties were compared with those of other
antibacterial systems reported in the literature. For example,
under white light conditions (40 000 lux), protoporphyrin- and
zinc protoporphyrin-grafted nylon ﬁbers resulted in 5.6%
reduction in the numbers of S. aureus, whereas they did not
show signiﬁcant killing of E. coli.40 Moreover, Sehmi et al.
reported CV in combination with ∼18 nm ZnO NPs
incorporated in polyurethane squares. Upon illumination with
a white light source (6600 ± 990 lux), these polymer samples
caused lethal photosensitization of both E. coli and S. aureus in
1 and 4 h, respectively.41
In our previous work, CV was encapsulated into PDMS
squares in combination with ZnO NPs used in the present
study, and they demonstrated signiﬁcant antibacterial activity
against S. aureus and E. coli in 1 and 4 h, respectively, under
white light conditions (∼10 500 lux).42 These results validate
the potent photobactericidal activity observed with the
5.0ZnO−CV surfaces reported here, achieving decreases in
bacterial numbers of greater than 4 logs for both S. aureus and
E. coli in only 45 and 90 min, respectively.
These antibacterial materials can also be compared with
other antibacterial surfaces that showed enhanced antibacterial
activity. For example, at a much lower white light intensity of
∼500 lux, signiﬁcant lethal photodestruction of S. aureus and E.
coli was achieved using polyurethane samples containing the
combination of CV and ZnO NPs (∼2−4 nm in size). This
enhanced antibacterial eﬃcacy may be ascribed to the small size
of ZnO NPs because there is a correlation between the
decreasing size of ZnO NPs and their antibacterial
activity.19,43,44 However, this method involves complex,
laborious, time-consuming synthesis of the NPs and is only
applicable to soft materials. Therefore, the proposed method in
this study outperforms its counterparts in many aspects such as
its easy fabrication, the low-cost materials utilized, and the
material’s high versatility for being coated on a wide range of
substrates (e.g. metal, glass, paper, and soft polymer plates)
(see Supporting Information, Figure S5).
The antibacterial behavior of CV is well established. Upon
light activation of the dye, two diﬀerent photochemical reaction
pathways occur simultaneously: one generates hydroxyl radicals
(•OH) and superoxide ions (O2
•−) through the electron
transfer process (type I) and the other generates singlet oxygen
(1O2) through energy transfer (type II).
45 Photogenerated ROS
can attack bacteria via a non-site-speciﬁc multiple attack
mechanism (unlike antibiotics, which usually have a singlet
target) including the disruption of cellular membranes and
DNA by means of oxidative damage, making bacteria unlikely
to develop resistance because resistance normally occurs when
a bactericide has a single target.14,46,47
In contrast to that of CV, the killing mechanism of ZnO is
still unclear, but there are various mechanisms proposed in the
literature, including the production of ROS,19,20,48−52 the
release of zinc ions,21,48,53,54 and the accumulation of NPs in
the bacterial cytoplasm and on the outer membrane of Gram-
negative bacteria.19 Some studies showing signiﬁcant anti-
bacterial activity of ZnO in the dark attributed this to the
release of zinc ions from a ZnO suspension, which penetrate
into the bacteria, damaging DNA and resulting in cell
death.23,55,56 However, there are many studies indicating that
the concentrations of released Zn2+ ions were not high enough
to cause nanotoxicity.19,20,57,58 Lakshmi et al. proved that its
antibacterial activity is mainly attributed to ROS in the dark59
rather than release of zinc ions (zinc ion dissolution) and ZnO
internalization.22,23,60,61 The presence of surface defects on
ZnO NPs can generate ROS under lower-energy-light
illumination (i.e., visible light). Previous study has demon-
strated that the encapsulation of ZnO in combination with CV
into polyurethane can increase the photobactericidal activity of
the dye via both type I and type 2 pathways,41 which is in good
agreement with the data presented here.
Regarding real-world applications, antimicrobial materials
should to be durable, environmentally friendly, and not harmful
to humans.62 Therefore, it is imperative that the dye
incorporated in the polymer does not leach signiﬁcantly or
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rub oﬀ upon contact with hands or disinfectant wipes that are
often used to reduce the risk of the spread of infection. We
have demonstrated that the dye-coated samples proved to be
stable to contact with aqueous solution at 37°. The amount of
dye leached from the samples was relatively small relative to the
concentration (20 000 ppm), resulting in dermal irradiation or
sensitization over an extended period of clinical assessment.36
Furthermore, to determine the stability of the modiﬁed
polymers against standard hospital hygiene regime conditions,
they were vigorously wiped with Clinell wipes that are utilized
to clean hard surfaces on the wards in University College
London Hospital NHS Trust hospitals. There was no visual
evidence of dye removal from the modiﬁed polymer after
rigorous wiping with 70% alcohol, proving its robustness
against our standard hospital cleaning protocol and, hence,
transmission of dye upon touching is unlikely. Similarly, the
leaching of ZnO NPs and their transfer by human contact is
minimal because we have shown that they are well embedded
into the polymer. ZnO NPs have been widely utilized in the
cosmetics and food industry, and their toxicity in humans has
been extensively investigated, with the conclusion that it
depends on many factors such as their size, shape, route of
administration, and dosage. Studies have showed that their
penetration through skin is improbable although other routes of
administration of these nanoparticles can demonstrate harmful
eﬀects at high doses (>100 μg mL−1).63,64
3. CONCLUSIONS
In this study, ZnO NPs have been successfully embedded with
diﬀerent nanoparticle concentrations in PDMS, followed by
incorporating CV using a simple swell−encapsulation−shrink
process to fabricate white-light-activated antibacterial surfaces.
The ZnO/CV composites possess superior antibacterial
activities that are dependent upon the concentration of zinc
in the polymer ﬁlms. Among them, the 5.0ZnO−CV composite
is proved to be one of the most eﬃcacious antibacterial
polymer surfaces developed to date, active in light conditions
relevant to U.K. hospitals and exhibiting lethal photosensitiza-
tion of S. aureus in just 45 min and of E. coli in just 90 min, with
a minimum of a 4 log reduction in the numbers of both
bacteria. Because release or transmission of dye and nano-
particle upon using this polymer coating is improbable, it has
potential applications from healthcare settings (e.g., doors and
hospital bed rails) to electronic devices (e.g., tablet and mobile
phone covers) to help reduce bacterial surface contamination
and thus reduce the risk of the spread of infection.
4. MATERIALS AND METHODS
4.1. Chemicals and Substrates. All chemicals used in this
study were purchased from Sigma-Aldrich Chemical Co. except
for acetone (VWR, U.K.). The PDMS prepolymer and curing
agent (SYLGARD 184) were purchased from Dow Corning
Corporation.
4.2. Materials Synthesis. 4.2.1. Preparation of ZnO NPs/
PDMS Composites. Polymer/nanoparticle composites with
various ZnO contents (0, 0.5, 1, and 5 wt %) were produced.
The appropriate amount of ZnO NPs was dispersed in PDMS
(monomer/crosslink = 10:1 in mass), and the mixture was
homogenized by hand-stirring. Afterward, the slurry was
degassed in a desiccator for 15 min, followed by casting on
glass substrates and they were cured in a preheated oven (100
°C) for 45 min. After the cooling, the polymer sheets were
peeled oﬀ from the substrates and were cut into smaller pieces
(squares 2.0 cm × 2.0 cm).
4.2.2. Preparation of Polymers with Embedded Crystal
Violet. Bare PDMS and ZnO-incorporated samples were coated
with CV (by placing 2 cm × 2 cm squares into 750 ppm
solutions of CV in acetone for 24 h) before removal, washed,
and air-dried (24 h).
4.3. Material Characterization. Transmission electron
microscopy (TEM) images were taken using JEOL JEM
1200EX with a 4 megapixel Gatan Orius SC200 charge-coupled
device camera at an acceleration voltage of 120 kV.
The infrared absorbance spectra of the modiﬁed polymer
samples were recorded within the range of 1000−4000 cm−1
with an accumulation of 16 scans per sample using a Bruker
Platinum ATR.
X-ray diﬀraction patterns of the modiﬁed samples were
recorded using a Stoe diﬀractometer with monochromated Mo
Kα1 radiation (λ = 0.7093 Å) in transmission mode over the
angle range 20−70°/2θ°.
The photoluminescence (PL) spectra of the treated samples
were recorded using a Fluoromax 4.0 Jobin Yvon Horiba
spectroﬂuorometer.
UV−vis absorption spectra of the ZnO NP aqueous
suspension and CV-coated polymer samples were measured
using a PerkinElmer Lambda 950 UV−vis spectrometer over a
range of 200−800 nm (full range not shown).
Water contact angle measurements were performed using an
FTA-1000 drop shape instrument. A 3 μL water droplet was
dropped onto the surface of the samples, and the contact angle
of the droplet was calculated using FTA32 software.
4.4. Functional Testing. 4.4.1. Leaching Test. The
stability of the CV-coated PDMS polymers in solution was
examined by immersing 2 cm2 squares in phosphate-buﬀered
saline (PBS) (10 mL) at 37 °C for an extended period of time.
The concentration of CV that leached into the PBS solution
was recorded periodically using UV−vis spectroscopy (596 nm,
Pharmacia Biotech Ultrospec 2000) and by comparing the
absorbance of PBS at 596 nm with a CV calibration curve.
4.4.2. Dye Adherence Testing. All samples containing crystal
violet were wiped rigorously with a 70% isopropyl alcohol wipe
(AZOwipeTM, Synergy Health) to determine whether the dye
adhered to the sample surface under standard cleaning regimes.
4.4.3. Bactericidal Assay. The following polymer samples (2
cm × 2 cm) were utilized in the bactericidal assays: bare PDMS
polymer (control), zinc oxide-incorporated PDMS (ZnO),
crystal violet-coated PDMS (CV), 0.5% ZnO-doped PDMS
(0.5ZnO), 0.5% ZnO-doped PDMS with CV (0.5ZnO−CV),
1% ZnO-doped PDMS (1.0ZnO), 1% ZnO-doped PDMS with
CV (1.0ZnO−CV), 5% ZnO-doped PDMS (5.0ZnO), and 5%
ZnO-doped PDMS with CV (5.0ZnO−CV). These samples
were evaluated against E. coli ATCC 25922 and S. aureus 8325-
4. These organisms were stored at −70 °C in brain−heart-
infusion broth (BHI, Oxoid) containing 20% (v/v) glycerol and
propagated on either MacConkey agar (Oxoid Ltd.) in the case
of E. coli or mannitol salt agar (Oxoid Ltd.) in the case of S.
aureus, for a maximum of two subcultures at intervals of 2
weeks.
A single colony of either E. coli or S. aureus was cultured in
BHI broth (10 mL) for 17 h, shaking at 37 °C. The bacterial
pellet was harvested by centrifugation (20 °C, 4000 rpm, 5
min) and washed in PBS (10 mL). After centrifugation again
under the same conditions, the bacteria were resuspended in
PBS (10 mL). The washed bacterial suspension was then
ACS Omega Article
DOI: 10.1021/acsomega.7b01473
ACS Omega 2018, 3, 3190−3199
3196
diluted 1 in 1000 in PBS to give an inoculum of ∼106 CFU
mL−1.
Duplicates of each polymer sample were inoculated with 25
μL of the inoculum and covered with a sterile cover slip (1.8 cm
× 1.8 cm). The samples were then irradiated for the required
time period using a white light source that emits an average
light intensity of 6500 ± 300 lux at a distance of 25 cm from the
samples. A further set of samples (in duplicate) was maintained
under dark conditions for the duration of the irradiation time.
Post irradiation, the inoculated samples and cover slips were
transferred to a tube containing PBS (5 mL) and vortexed (60
s). The neat suspension and 10-fold serial dilutions were plated
on the appropriate agar. The plates were incubated aerobically
for 24 h (E. coli) or for 48 h (S. aureus) at 37 °C, and the were
colonies enumerated to determine the number of viable
bacteria. The bacterial numbers in the inoculum were also
determined in each experiment by viable colony counting. Each
experiment contained two technical replicates, and the
experiment was reproduced three times. The Mann−Whitney
U test was used to analyze the statistical signiﬁcance of the data.
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